The category of Type II 4-phosphatase β Inhibitors would encompass a diverse array of compounds with the capability to modulate the activity of type II phosphatases or affect related cellular signaling cascades. These inhibitors operate through a variety of mechanisms, underscoring the complexity and critical nature of phosphatase functions in cellular processes. Direct inhibitors such as Sodium orthovanadate and Calyculin A demonstrate the capacity to alter signaling pathways by affecting the phosphorylation state of proteins. This modulation is essential for the regulation of numerous cellular functions, including growth, differentiation, and apoptosis, highlighting the significance of phosphatases in maintaining cellular homeostasis.
Moreover, the inclusion of compounds like Okadaic acid and Cantharidin offers insights into the regulatory mechanisms that govern cell cycle progression and signal transduction. Their specific inhibition of protein phosphatases like PP1 and PP2A points to the potential for targeted modulation of phosphatase activity as a means to study and influence the complex networks of cellular signaling. Additionally, natural toxins such as Microcystin-LR emphasize the potent effects that phosphatase inhibition can exert on cellular physiology, affecting a broad range of biological processes from cytoskeletal organization to gene expression.
In sum, this theoretical class of Type II 4-phosphatase β Inhibitors illustrates the critical roles that phosphatases play in regulating cellular functions and the potential for chemical compounds to influence these processes through direct or indirect interactions. By targeting the activity of these enzymes, it is possible to affect a wide array of biological pathways, offering a window into the sophisticated signaling networks that underpin cellular behavior. This approach not only provides a foundation for understanding the impact of phosphatase modulation on cell physiology but also underscores the intricate balance of phosphorylation and dephosphorylation events essential for proper cellular function.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Acts as a competitive inhibitor of protein tyrosine phosphatases, altering phosphorylation states. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Strongly inhibits protein phosphatases 1 and 2A, which could affect related phosphatase activities. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Targets protein phosphatases PP1 and PP2A, potentially altering signaling pathways involving similar phosphatases. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Inhibits serine/threonine phosphatases, including PP2A, which may influence related phosphatase signaling. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Selective inhibitor of PP2A and PP4, could impact signaling pathways mediated by similar phosphatases. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits PP1 and PP2A, affecting phosphorylation dynamics and signaling pathways of related enzymes. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Acts against PP2A, potentially influencing pathways involving similar type II phosphatases. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Binds and inhibits tyrosine phosphatases, potentially affecting signaling pathways of related enzymes. | ||||||
Bialaphos Sodium Salt | 71048-99-2 | sc-280620 sc-280620A | 100 mg 500 mg | $450.00 $992.00 | 1 | |
While its primary action is on protein synthesis, it could indirectly influence phosphatase activity. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Indirectly targets phosphatases involved in ER stress, potentially affecting related enzymes. | ||||||